BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03763149-completion@plaintrial.com
DTSTAMP:20261111T000345Z
DTSTART;VALUE=DATE:20210329
SUMMARY:A Study Evaluating the Safety\, Tolerability\, and Initial Efficacy
  of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoc
 lonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumo
 rs and Lymphomas — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03763149
URL:https://plaintrial.com/trial/NCT03763149
END:VEVENT
END:VCALENDAR